Why a medical device takes years to reach the ward.

The prototype works. It measures what it should, it fits in a nurse's hand and the first clinicians to try it want one. In consumer hardware, that is the moment to start manufacturing. In medical devices, it is closer to the moment the real project begins.

The gap surprises founders because it is mostly invisible. It is filled with documents, tests, audits and clinical evidence, all of which exist to answer one question for a regulator and a hospital: can we trust this device with a patient?

Design controls start earlier than you think

Regulators expect a device to be designed under a quality system, with design controls that trace every requirement to a test that proves it is met. Teams that built their prototype informally often have to go back and document, or redo, work they thought was finished. Starting a quality system early, even a lightweight one, is usually cheaper than reconstructing one later.

Two words matter here. Verification shows the device was built the way it was specified. Validation shows that what was specified actually meets the needs of the people who use it, in the setting where they use it. Both need evidence.

“

We had a finished product and an unfinished file. The file took longer.

The regulatory route sets the clock

How long the next stage takes depends on the device's risk class and the market. In the United States, many moderate-risk devices are cleared through the FDA's 510(k) route by showing they are substantially equivalent to a device already on the market, while novel high-risk devices need premarket approval, which usually requires clinical data. In the European Union, the Medical Device Regulation requires most devices beyond the lowest class to be assessed by a notified body.

Each route has its own evidence bar, and choosing one is a strategic decision as much as a regulatory one. A device designed to fit an existing category can sometimes reach market far sooner than one that creates a new category.

Then the hospital has its own questions

Clearance lets a device be sold. It does not make anyone buy it. Hospital procurement teams want to know how the device fits existing workflows, what training it needs, how it connects to their systems, who services it and whether there is evidence it improves outcomes or saves money. Pilots and health-economic data often take as long to assemble as the regulatory file.

None of this is a reason not to build medical devices. It is a reason to plan the evidence alongside the engineering from the first month, and to fund the company for the whole road rather than just the prototype.